Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

Vascular Innovation on Display: The VIVA Foundation Set to Unveil Latest Trial Data at The VEINS and VIVA 2025

September 10, 2025

PALM SPRINGS, Calif., September 10, 2025 /PRNewswire/ — The VIVA Foundation will once again showcase the most influential new data in vascular medicine on a global stage. From Saturday, November 1, through Tuesday, November 4, results from 23 clinical trials will be presented during The VEINS and VIVA conferences at Wy ...

News & Updates

Dr. Kush R. Desai Appointed to The VIVA Foundation Board of Directors

December 18, 2024

The VIVA Foundation has appointed Kush R. Desai, MD, FSIR, as the newest member of the Board of Directors. The Foundation is a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education, research, advocacy, and collaboration. Dr. Desai has collaborated with The ...

News & Updates

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

November 5, 2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVentional Advanc ...

News & Updates

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

November 5, 2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVention ...

News & Updates

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

November 4, 2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials presented at the VIVA24 conference, at Wynn Las Vegas. VIVA (Vascular InterVentio ...

Load More